Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2011 Filed Jul 27, 2017 10:48 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10.55 | $0.04 | $0.41 |
DisclosureSEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,502,292 Read SEC document |
| July 05, 2011 Filed Jul 27, 2017 10:48 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 2,594 | $0.04 | $103.76 |
DisclosureSEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,512,842 Read SEC document |
| July 01, 2011 Filed Jul 27, 2017 10:48 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 800 | $0.04 | $32.80 |
DisclosureSEC source: 0001511164-17-000427 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,515,436 Read SEC document |
| June 30, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 30 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,516,236 Read SEC document |
| June 23, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 7,100 | $0.04 | $291.10 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 29 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,526,236 Read SEC document |
| June 22, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.04 | $185.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 28 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,533,336 Read SEC document |
| June 22, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.04 | $175.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 27 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,538,336 Read SEC document |
| June 15, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 4,100 | $0.05 | $192.70 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 26 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,543,336 Read SEC document |
| June 15, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 20,000 | $0.04 | $840.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 25 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,547,436 Read SEC document |
| June 15, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $410.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 24 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,567,436 Read SEC document |
| June 15, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.04 | $200.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 23 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,577,436 Read SEC document |
| June 14, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 35,400 | $0.04 | $1,416.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 22 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,582,436 Read SEC document |
| June 10, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 20,000 | $0.03 | $680.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 21 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,617,836 Read SEC document |
| June 09, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 20,000 | $0.03 | $680.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 20 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,637,836 Read SEC document |
| June 08, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 11,480 | $0.03 | $390.32 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 19 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,657,836 Read SEC document |
| June 08, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.03 | $330.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 18 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,669,316 Read SEC document |
| June 06, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 15,071 | $0.04 | $542.56 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 17 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,679,316 Read SEC document |
| June 02, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $360.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 16 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,694,387 Read SEC document |
| March 23, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $350.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 15 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,704,387 Read SEC document |
| March 23, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.03 | $330.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 14 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,714,387 Read SEC document |
| March 23, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 6,000 | $0.03 | $186.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 13 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,724,387 Read SEC document |
| March 14, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 1,000 | $0.04 | $40.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 12 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,730,387 Read SEC document |
| March 11, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.03 | $270.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 11 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,731,387 Read SEC document |
| March 09, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.03 | $135.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 10 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,741,387 Read SEC document |
| March 09, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.03 | $125.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 9 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,746,387 Read SEC document |
| March 07, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 7,480 | $0.03 | $209.44 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 8 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,751,387 Read SEC document |
| March 04, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.03 | $280.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 7 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,758,867 Read SEC document |
| March 02, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 5,000 | $0.03 | $140.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 6 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,768,867 Read SEC document |
| February 18, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $420.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,773,867 Read SEC document |
| February 18, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,783,867 Read SEC document |
| February 14, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.05 | $520.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,793,867 Read SEC document |
| February 11, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.05 | $520.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,803,867 Read SEC document |
| February 11, 2011 Filed Jul 27, 2017 10:09 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 20,000 | $0.05 | $1,000.00 |
DisclosureSEC source: 0001511164-17-000424 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,813,867 Read SEC document |
| December 31, 2010 Filed Jul 26, 2017 12:21 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000414 · primary_doc.xml · nonDerivative · entry 5 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,833,867 Read SEC document |
| December 31, 2010 Filed Jul 26, 2017 12:21 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 20,000 | $0.04 | $760.00 |
DisclosureSEC source: 0001511164-17-000414 · primary_doc.xml · nonDerivative · entry 4 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,843,867 Read SEC document |
| December 30, 2010 Filed Jul 26, 2017 12:21 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 7,500 | $0.04 | $285.00 |
DisclosureSEC source: 0001511164-17-000414 · primary_doc.xml · nonDerivative · entry 3 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,863,867 Read SEC document |
| December 29, 2010 Filed Jul 26, 2017 12:21 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 12,000 | $0.04 | $456.00 |
DisclosureSEC source: 0001511164-17-000414 · primary_doc.xml · nonDerivative · entry 2 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,871,367 Read SEC document |
| December 29, 2010 Filed Jul 26, 2017 12:21 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $360.00 |
DisclosureSEC source: 0001511164-17-000414 · primary_doc.xml · nonDerivative · entry 1 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,883,367 Read SEC document |
| December 27, 2010 Filed Jul 3, 2017 14:35 UTC |
Bowdring Robert Joseph JrChief Financial Officer
|
GrantINVO Bioscience Common Stock (Restricted) | 2,500,000 | $0.01 | $25,000.00 |
DisclosureSEC source: 0001185185-17-001492 · form5-bowdring123110.xml · nonDerivative · entry 1 Bowdring Robert Joseph Jr · CIK 0001664410 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500,000 Read SEC document |
| December 27, 2010 Filed Jul 3, 2017 15:14 UTC |
Karloff Kathleen tDirector · CEO/Chairman
|
GrantINVO Bioscience Common Stock (Restricted) | 1,012,841 | $0.01 | $10,128.41 |
DisclosureSEC source: 0001185185-17-001510 · form5-karloff123110.xml · nonDerivative · entry 1 Karloff Kathleen t · CIK 0001493763 · Director · CEO/Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,960,000 Read SEC document |
| December 27, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
GrantINVO Bioscience Common Stock (Free trading) | 650,000 | $0.01 | $6,500.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 30 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,893,367 Read SEC document |
| December 27, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 29 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,243,367 Read SEC document |
| December 22, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $390.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 28 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,253,367 Read SEC document |
| December 22, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $400.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 27 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,263,367 Read SEC document |
| December 17, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $420.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 26 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,273,367 Read SEC document |
| December 17, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.05 | $480.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 25 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,283,367 Read SEC document |
| December 13, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $420.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 24 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,293,367 Read SEC document |
| December 13, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.05 | $450.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 23 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,303,367 Read SEC document |
| September 21, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.05 | $450.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 22 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,313,367 Read SEC document |
| September 21, 2010 Filed Jul 26, 2017 12:08 UTC |
Ranoux ClaudeDirector · President · 10% owner
|
Disposition to issuerINVO Bioscience Common Stock (Free trading) | 10,000 | $0.04 | $350.00 |
DisclosureSEC source: 0001511164-17-000413 · primary_doc.xml · nonDerivative · entry 21 Ranoux Claude · CIK 0001479791 · Director · President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,323,367 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.